Episoder
-
In this On Demand video, Dr. Steve Ommen and Dr. Carolyn Ho discuss recent updates to the 2024 Guideline for the Management of Hypertrophic Cardiomyopathy (HCM). Watch now to enhance your knowledge on the importance of shared decision-making, the use of cardiac myosin inhibitors to treat symptomatic obstructive HCM, and risk stratification for atrial fibrillation to improve patient outcomes.
-
Manglende episoder?
-
Making the correct of hypertrophic cardiomyopathy (HCM) is critical in being able to initiate early surveillance and therapy to improve patient outcomes. In this podcast focusing on pharmacologic treatment options, learn more about completed and ongoing myosin inhibitor clinical trials.
-
Accurate diagnosis of Hypertrophic Cardiomyopathy (HCM) is critical. HCM is a chronic and progressive disease putting patients at risk of serious complications and co-morbidities. Early and correct detection may help reduce some of the consequences of HCM and improve outcomes. In this podcast, learn more about how to distinguish phenocopies from HCM.
-
Although the cardiovascular and overall health benefits of regular activity are well-established, recommendations for recreational exercise and competitive sports participation for patients with HCM have been challenging. Listen to this podcast as Drs. Abraham, Day, and Martinez along with Brian Metz discuss exercising with HCM and the importance of shared decision making with the healthcare team.
-
Hypertrophic cardiomyopathy (HCM) is the most common form of genetic heart disease and can affect people of any age, yet it often goes undiagnosed. Genetic testing and counseling plays an important role in the diagnosis and management of HCM in patients in families. Learn more about genetic testing and counseling, and its impact on the patient’s family.
-
People with HCM are at increased risk for developing arrythmias such as atrial fibrillation, suffering from stroke and even sudden cardiac arrest. People with HCM face a risk of death more than 3 times greater than the average person of the same age without HCM. Learn more about the complex relation between atrial fibrillation and hypertrophic cardiomyopathy.
-
Surgical and interventional options such as surgical myectomy or alcohol septal ablation may help those with obstructive Hypertrophic Cardiomyopathy (HCM) to reduce or remove the obstruction. A similar option is unavailable to those with non-obstructive HCM. Heart transplants are considered as a last resort for HCM patients who progress to end stages of the disease. Learn more about advanced surgical approaches and emerging medical therapies for HCM.
-
This podcast on hypertrophic cardiomyopathy, covers the natural history of the disease with a focus on the patient's perspective, tracking patient's symptoms and function, as far as disease progression is concerned, exploring the nuances of obstructive and non-obstructive forms of this disease, how it's managed depending on its form, and what is the burden that this disease brings to both patients and clinicians worldwide.
-
Hypertrophic Cardiomyopathy is a disease condition that has over seven decades of knowledge. HCM manifests as 3 clinical pathways and may be synonymous with a normal lifespan with currently available therapies. Listen to Dr. Robert Fraser, Dr. Miguel Leal, and Dr. Ferhaan Ahmad provide an introduction of Hypertrophic Cardiomyopathy and help improve the care of affected patients through early symptom recognition, diagnosis, and treatment.
-
Learn how to distinguish hypertrophic cardiomyopathy (HCM) from other disorders that can look like HCM. Listen as Dr. Vlad Zaha and Dr. Ferhaan Ahmad discuss how healthcare professional make a diagnosis of HCM and how they distinguish it from other disorders and the complex nature of diagnosing hypertrophic cardiomyopathy.
